ADA (American Diabetes Association) June 20-23 Obesity Medicines – Other Posters and Talks

🧪 NA‑931 (Bioglutide™) – Biomed Industries, Inc.Presentation (Oral):Title: “Phase 2 Clinical Trials of NA‑931, an Oral Novel Quadruple IGF‑1, GLP‑1, GIP, and Glucagon Receptor Agonist, Reduces Body Weight Without Muscle Loss.”Presenter: Dr. Lloyd L. Tran (CEO)Date & Time: June 20, 2025 – oral session (specific time TBD at conference)Poster:Title: “Association Between Alzheimer’s Disease (AD) and Obesity: Clinical Trial […]

Court upholds FDA removal of semaglutide from drug shortage list

A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to allow them to continue making copies of the drugs, The Hill reported June 18.  U.S. District Judge Mark Pittmann ruled June 17 that […]

WeightWatchers takes drastic step to exit bankruptcy

Growing up, I always knew when it was “weigh-in day.” My mom would slip into the kitchen in the early morning and emerge with her little tracker notebook tucked under one arm and a low-point snack in the other. I was fascinated. She had little bars in shiny wrappers, chocolate-covered pretzels that somehow counted as […]

Your DNA could be stopping you from losing weight, new study suggests

Your genetic makeup could be the reason you’re not losing weight. New research from Harvard T.H. Chan School of Public Health and Ben Gurion University in Israel found that one-third of people who followed a healthy diet did not lose any weight — although they did still experience health benefits. Participants exhibited “significant improvements” in […]

Omada Health Data Shows Companion Program Significantly Boosts GLP-1 Medication Persistence

What You Should Know:  – Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications.  – The analysis found that members in Omada’s program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support […]

Telling the Good from the Bad Compounded GLP-1 Drugs

The surge in demand for GLP-1 medicines has led to a market made up of compounded versions sold online. While compounding pharmacies are essential for patients who can’t medically tolerate FDA-approved drugs or helping to alleviate shortages, the rise of compounded GLP-1s indicates a troubling oversight issue as distinguishing good actors from bad ones is […]

Influencer Reacts to Criticism ‘Ozempic Is Cheating’ After GLP-1 Weight Loss

Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight. “‘Ozempic is cheating.’ ‘Ozempic is the easy way out,’” Rohner wrote via Instagram on Tuesday, June 17. “Here is my experience: You still need to prioritize macros, especially protein and fiber you need to continue to fuel your […]

FDA’s removal of Ozempic, Wegovy from drug shortage list upheld

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the drugs, was lawful and that the agency acted correctly. U.S. District Court Judge Mark Pittman found that the Outsourcing Facilities Association (OFA), an organization […]